Picture of Standard BioTools logo

LAB — Standard BioTools News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Fluidigm Corp expected to post a loss of 19 cents a share - Earnings Preview

* Fluidigm Corp  FLDM.OQ   FLDM.O  is expected to show a rise in
quarterly revenue when it reports results on August 5. 
* The South San Francisco, California-based company is expected
to report   a 19.0% increase in revenue to $31.016 million from
$26.06 million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Fluidigm Corp is for a
loss of 19 cents per share. For the same quarter last year, the
company reported a loss of 18 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Fluidigm Corp
is $9.5​, about 26.3% above​ its last closing price
of $7.00. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.12       -0.14      -0.25     Missed  -74.4
 Dec. 31 2020  -0.03       -0.07      -0.24     Missed  -260
 Sep. 30 2020  -0.18       -0.20      -0.08     Beat    60​
 Jun. 30 2020  -0.23       -0.23      -0.18     Beat    21.7
 Mar.          -0.14​      -0.15      -0.23     Missed  -53.3​
 31​ 2020​                                              
 Dec. 31 2019  -0.19       -0.19      -0.18     Beat    4.3​
 Sep. 30 2019  -0.20       -0.20      -0.19     Beat    5.9
 Jun. 30 2019  -0.23       -0.21      -0.20     Beat    3.8
 This summary was machine generated August 4 at 00:28 GMT.  All
figures in US dollars unless otherwise stated

Recent news on Standard BioTools

See all news